PECULIARITIES OF CLINICAL AND INSTRUMENTAL INDICATORS OF COMMUNITY-ACCOMPANY PNEUMONIA WITH MYOCARDITIS IN CHILDREN
Abstract
Worldwide, pneumonia is the leading cause of morbidity and mortality in children under 5 years of age. Although the majority of childhood pneumonia-related deaths occur primarily in developing countries, the disease burden is substantial and there are significant public health costs associated with pneumonia in developed countries. Our data suggest that the incidence of myocarditis in children with pneumonia may be higher than previously known. Since myocarditis can be a fatal disease, its detection is important through non-invasive methods such as ECG, echocardiography, and measurement of cardiac enzymes. High levels of CK-MB were found in all patients who died and in six out of seven patients with congestive heart failure. Our data suggest that the incidence of myocarditis in children with pneumonia may be higher than previously known. Since myocarditis can be a fatal disease, its detection is important through non-invasive methods such as ECG, echocardiography, and measurement of cardiac enzymes. High levels of CK-MB were found in all patients who died and in six out of seven patients with congestive heart failure. Our data suggest that the incidence of myocarditis in children with pneumonia may be higher than previously known. Since myocarditis can be a fatal disease, its detection is important through non-invasive methods such as ECG, echocardiography, and measurement of cardiac enzymes. The paper presents the results of anamnestic, clinical, conventional laboratory and special methods of examination in 80 children with community-acquired pneumonia aged 1 to 6 years, of which 40 patients with concomitant myocarditis who were hospitalized in departments II of emergency pediatrics and children's resuscitation of Samarkand branch of the Republican Scientific Center for Emergency Medical Care in the period from 2020 to 2022.